:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Gerlinde Freimark, Sebastian Strauss, Lucas H. Overeem, Mira P. Fitzek, Kristin S. Lange, Carolin L. Höhne, Uwe Reuter, Robert Fleischmann, Bianca Raffaelli
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Headache: The Journal of Head and Face Pain
Online Access:	https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.15021
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Early effect of onabotulinumtoxinA on EEG ‐based functional connectivity in patients with chronic migraine: A pilot study
by: Matteo Conti, et al.
Published: (2024)

The safety and efficacy of onabotulinumtoxinA injections for children and adolescents with chronic migraine: A systematic review and meta‐analysis
by: Rebecca Lindsay, et al.
Published: (2024)

The impact of the migraine treatment onabotulinumtoxinA on inflammatory and pain responses: Insights from an animal model
by: Philip Victor Reducha, et al.
Published: (2024)

Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A retrospective tolerability and safety study
by: Christopher C. Anderson, et al.
Published: (2024)

Remote electrical neuromodulation for reducing procedural pain in patients with chronic migraine receiving onabotulinumtoxinA injections: A randomized sham‐controlled study
by: Nan Cheng, et al.
Published: (2025)

Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials
by: Stephen D. Silberstein, et al.
Published: (2024)

The role of stress in the comorbidity of migraine and other chronic primary pain
by: Shi‐Jie Zhao, et al.
Published: (2025)

Effectiveness and acceptability of oral migraine preventives: A prospective, observational study
by: Hedda S. Riise, et al.
Published: (2026)

Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
by: Shuu‐Jiun Wang, et al.
Published: (2024)

Clinical factors associated with day‐to‐day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data
by: Marina Vives‐Mestres, et al.
Published: (2024)

Evaluating dual calcitonin gene‐related peptide antagonists for chronic migraine prevention
by: Kara S. Graves, et al.
Published: (2026)

Impact of perilesional edema on severity of migraine in patients with calcified neurocysticercosis: A prospective evaluation
by: Vishwesh Vishnu Naik, et al.
Published: (2025)

Glial activation in pain and emotional processing regions in the nitroglycerin mouse model of chronic migraine
by: Haley C. Cropper, et al.
Published: (2024)

Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache
by: Andrew Blumenfeld, et al.
Published: (2024)

Afterimage duration differs for migraine with or without aura
by: Florian Rimmele, et al.
Published: (2025)

Sex influences the progression of cephalic mechanical and light hypersensitivities in a mouse model of chronic migraine
by: Marie Raquin, et al.
Published: (2025)

Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A randomized controlled trial
by: Ghader Mohammadnezhad, et al.
Published: (2024)

Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study
by: Maggie R. Mittleman, et al.
Published: (2024)

Maternal and child mental health and incident migraine in adolescence: An “All Our Families” prospective cohort study
by: Kirsten Sjonnesen, et al.
Published: (2026)

Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine
by: Anna de Dios, et al.
Published: (2024)

Letter to the Editor regarding “Impact of perilesional edema on severity of migraine in patients with calcified neurocysticercosis: A prospective evaluation”
by: Hinpetch Daungsupawong, et al.
Published: (2025)

Patient satisfaction with calcitonin gene‐related peptide monoclonal antibodies in migraine: A multicenter prospective cohort study
by: Alba López‐Bravo, et al.
Published: (2025)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
by: Graham A. McLeod, et al.
Published: (2025)

Functional impairment of chronic migraine with medication overuse: Secondary analysis from the Medication Overuse Treatment Strategy ( MOTS ) trial
by: Samantha C. Shao, et al.
Published: (2024)

Author response to comments on our article “Impact of perilesional edema on severity of migraine in patients with calcified neurocysticercosis: A prospective evaluation”
by: Ravi Uniyal, et al.
Published: (2025)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
by: Rikki Mangrum, et al.
Published: (2024)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
by: Yunus Emre Meydanal, et al.
Published: (2025)

Letter to the Editor regarding “Persistence, effectiveness, and tolerability of anti‐calcitonin gene‐related peptide monoclonal antibodies in patients with chronic migraine”
by: Joaquín Borrás‐Blasco, et al.
Published: (2025)

Evaluating associations of migraine‐related vertigo
by: Nazia Karsan, et al.
Published: (2025)

Circadian functional changes of pain‐processing brainstem nuclei and implications for cluster headache: A 7 Tesla imaging study
by: Heiko Pohl, et al.
Published: (2024)

Mechanisms for mindfulness in migraine: Does catastrophizing matter?
by: Rebecca Erwin Wells, et al.
Published: (2024)

Useful considerations for treating migraine in patients with autism
by: Sinifunanya E. Nwaobi
Published: (2026)

Lifestyle triggers of migraine: Sleep restriction and caffeine lower the threshold for migraine‐like responses in rats in a sex‐specific manner
by: Gabriel Camargo de Oliveira, et al.
Published: (2026)

No association between migraine and HLA alleles in a cohort of 13,210 individuals with migraine from the Danish Blood Donor Study
by: Inga Zalia Tummoszeit, et al.
Published: (2024)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
by: Chia‐Chun Chiang, et al.
Published: (2024)

Counting the cost: How migraine shapes lives and economies
by: Risako Shirane, et al.
Published: (2025)

Cardiovascular risk and triptan usage among patients with migraine
by: Ido Peles, et al.
Published: (2025)

Depression and anxiety are not associated with migraine outcomes in children and adolescents
by: Amy A. Gelfand
Published: (2024)

Cognitive and emotional mechanisms underlying migraine quality of life
by: Shiri Shinan‐Altman, et al.
Published: (2026)

Integrating gepants into clinical practice for the acute treatment of migraine
by: Richard B. Lipton, et al.
Published: (2026)